Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#4031 68-Gallium DOTANOC PET/CT pitfall in adnexal tumor

Introduction: PET/CT with 68Ga-DOTA is a commonly used tool in the baseline evaluation and follow-up of NETs due to its high specificity and sensitivity, showing better performance than CT in detecting primary and metastatic disease. However, we must know more about its normal physiological distribution, its variation in pathologies, and the possibility of confusion with benign processes to optimize its interpretation.

Conference:

Presenting Author:

Authors: González Devia D, Chaar-Lugo A, Rojas-Camacho J, Londoño-Schimmer E, Buriticá-Cifuentes C,

Keywords: Neuroendocrine tumor, 68Ga-DOTANOC, PET/CT, Rectal neuroendocrine tumor, Adnexal tumor, Pitfalls,

#3975 Patterns of radiotracer uptake in patients with resectable lung carcinoids undergoing preoperative functional imaging

Introduction: There is paucity of real-world data on the use of preoperative functional imaging (PFI) in patients (pts) with lung carcinoids (LC), and the association of radiotracer uptake (RU) with histology/outcomes.

Conference:

Presenting Author: Diamantopoulos L

Authors: Diamantopoulos L, Dimou A, Parikh K, Shanshal M, Schwecke A,

Keywords: carcinoid, lung, gallium, pet, somatostatin,

#3693 Gallium-68 DOTANOC PET/CT in locally advanced/metastatic WHO grade 2 gastroenteropancreatic neuroendocrine tumors – Clinical and prognostic impact in assessing progression free survival

Introduction: Ga-68 DOTANOC PET/CT based prognostic factors can help in risk-stratification of patients with locally advanced/metastatic GEP-NETs.

Conference:

Presenting Author:

Authors: Dev I, Rangarajan V, Purandare N, Agrawal A, Shah S,

Keywords: Ga-68 DOTANOC, PET/CT, Grade 2 NET, SUVmax, liver involvement,

#3687 Lutetium-177 DOTATATE PRRT versus PRRT plus chemotherapy in metastatic well differentiated FDG-avid GEP-NETs – Results from a prospective cohort

Introduction: Combination therapy with PRRT and Capecitabine-Temozolomide (CAPE-TMZ) has benefited patients with FDG avid well-differentiated GEP-NETs.

Conference:

Presenting Author:

Authors: Puranik A, Rangarajan V, Shrikhande S, Ramaswamy A, Ostwal V,

Keywords: PRRT, capecitabine, temozolomide, FDG PET, DOTA PET,

#3436 Prognostic factors in 382 patients treated with 177-Lu-DOTATATE: Data from the SEPTRALU registry

Introduction: The aim was to describe prognostic variables in patients treated with 177Lu-DOTATATE (PRRT).

Conference:

Presenting Author:

Authors: Pubul V, Belló P, Hernando J, Rodeño E, Gajate P,

Keywords: somatostatin receptor-positive tumor, PRRT, prognostic variables,